Arterial intima-media thickness: site-specific associations with HRT and habitual exercise

2002 ◽  
Vol 283 (4) ◽  
pp. H1409-H1417 ◽  
Author(s):  
Kerrie L. Moreau ◽  
Anthony J. Donato ◽  
Douglas R. Seals ◽  
Frank A. Dinenno ◽  
Sharon D. Blackett ◽  
...  

We determined the site-specific relations of hormone replacement therapy (HRT) and habitual exercise status with intima-media thickness (IMT) in both elastic (carotid) and muscular (femoral) arteries in 77 healthy postmenopausal women: 43 women were sedentary (20 no-HRT and 23 HRT users) and 34 women were endurance trained (14 no-HRT and 20 HRT users). Femoral IMT was not different among the sedentary HRT and endurance-trained no-HRT and HRT groups, but was lower ( P < 0.005) in these three groups than in the sedentary no-HRT women. There were no significant group differences in carotid IMT. However, in older women (≥65 yrs) carotid IMT was smaller ( P < 0.05) in HRT compared with no-HRT women. We conclude that both endurance training and HRT status are independently associated with a smaller IMT and these effects are evident primarily in muscular arteries. These results suggest that HRT and habitual exercise may protect postmenopausal women against cardiovascular disease through influences on IMT. The site-specific relations may be due to a greater number of smooth muscle cells and plasticity of muscular arteries compared with elastic arteries and/or differences in heterogeneous influences such as metabolic requirements and hydrostatic pressures.

Life ◽  
2021 ◽  
Vol 11 (9) ◽  
pp. 919
Author(s):  
Éva Anna Piros ◽  
Ákos Szabó ◽  
Fanni Rencz ◽  
Valentin Brodszky ◽  
Klára Szalai ◽  
...  

Background: Psoriasis is frequently accompanied by cardiovascular diseases based on the shared immunopathogenic pathway. Authors determined the effect of interleukin (IL)-17 inhibitor therapy on arterial intima-media thickness (IMT) among severe psoriatic patients. Methods: Thirty-one severe psoriatic patients were enrolled. Twenty received secukinumab and 11 received ixekizumab. Before treatment initiation and after 6 months, the carotid-brachial-femoral IMT, the Psoriasis Area Severity Index (PASI), the Dermatology Life Quality of Index (DLQI) and the EuroQol Visual Analogue Scale (EQ VAS) were evaluated. Results: After 6 months, significant ameliorations were observed in PASI (p < 0.001) from 18 to 0, in DLQI (p < 0.001) from 17 to 0, in EQ VAS (p < 0.001) from 60 to 90, in right carotid IMT (p < 0.001) from 1.1 mm to 0.8 mm, in left carotid IMT (p < 0.001) from 1.1 mm to 0.7 mm, in right brachial IMT (p < 0.001) from 0.75 mm to 0.6 mm, in left brachial IMT (p < 0.001) from 0.8 mm to 0.5 mm, in right femoral IMT (p < 0.001) from 0.9 mm to 0.7 mm and in left femoral IMT (p < 0.001) from 0.8 mm to 0.7 mm. Conclusions: By reducing the inflammation of the vascular wall, anti-IL-17 therapy may have a beneficial long-term effect on cardiovascular complications of systemic inflammation.


2000 ◽  
Vol 153 (1) ◽  
pp. 81-88 ◽  
Author(s):  
Florence A. Tremollieres ◽  
Fabienne Cigagna ◽  
Cathy Alquier ◽  
Colette Cauneille ◽  
Jean-Michel Pouilles ◽  
...  

2010 ◽  
Vol 283 (5) ◽  
pp. 1045-1051 ◽  
Author(s):  
Hakan Coksuer ◽  
Mustafa Koplay ◽  
Fatih Oghan ◽  
Cengiz Coksuer ◽  
Nadi Keskin ◽  
...  

Maturitas ◽  
2004 ◽  
Vol 49 (2) ◽  
pp. 134-139
Author(s):  
Salvatore Santo Signorelli ◽  
Salvatore Sciacchitano ◽  
Vito Borzı̀ ◽  
Luigi Di Pino ◽  
Maria Pia Costa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document